Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats

Journal of Neurochemistry

Volumn 98, Issue 3, 2006, Pages 760-772

  Saint Pierre, Martine ^a   Tremblay, Marie Eve ^a   Sik, Attila ^b,c   Gross, Robert E ^d   Cicchetti, Francesca ^a,c,e  

^a Centre de Recherche en Neurosciences   (Canada)

^b CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

Dopamine; Fungicides; Herbicides; Inflammation; Parkinson's disease

Indexed keywords

FUNGICIDE; HERBICIDE; MANEB; PARAQUAT; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TOXICITY; CELL ACTIVATION; CELL LOSS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTRON MICROSCOPY; ENVIRONMENTAL EXPOSURE; GOLGI COMPLEX; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG INJURY; LUNG TOXICITY; MALE; MICROGLIA; NERVE CELL DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; SUBSTANTIA NIGRA;

AGING; ANIMALS; CELL DEATH; DOPAMINE; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; MALE; MANEB; MICROGLIA; NERVE DEGENERATION; NEURONS; PARAQUAT; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

ANIMALIA;

EID: 33745908586     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03923.x     Document Type: Article

References (64)

1. Arimoto T. and Bing G. (2003) Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration. Neurobiol. Dis. 12, 35-45.
2. Bareyre F. M. and Schwab M. E. (2003) Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays. Trends Neurosci. 26, 555-563.
3. Beal M. F. (2001) Experimental models of Parkinson's disease. Nat. Rev. Neurosci. 2, 325-334.
4. Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V. and Greenamyre J. T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306.
5. Bismuth C., Hall A. H., Baud F. J. and Borron S. (1996) Pulmonary dysfunction in survivors of acute paraquat poisoning. Vet. Hum. Toxicol. 38, 220-222.
6. Brooks A., Chadwick C., Gelbard H., Cory-Slechta D. A. and Federoff H. J. (1999) Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res. 823, 1-10.
7. Carvey P. M., Chang Q., Lipton J. W. and Ling Z. (2003) Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. Front. Biosci. 8, s826-s837.
8. Chanyachukul T., Yoovathaworn K., Thongsaard W., Chongthammakun S., Navasumrit P. and Satayavivad J. (2004) Attenuation of paraquat-induced motor behavior and neurochemical disturbances by 1-valine in vivo. Toxicol. Lett. 150, 259-269.
9. Cicchetti F., Lapointe N., Roberge-Tremblay A., Saint-Pierre M., Jimenez L., Ficke B. W. and Gross R. E. (2005) Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats. Neurobiol. Dis. 20, 360-371.
10. Corasaniti M. T., Strongoli M. C. and Nistica G. (1990) Determination of paraquat in rat brain using ion-pair solid-phase extraction and reversed-phase high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 527, 189-195.
11. Corasaniti M. T., Defilippo R., Rodino P., Nappi G. and Nistico G. (1991) Evidence that paraquat is able to cross the blood-brain barrier to a different extent in rats of various age. Funct. Neurol. 6, 385-391.
12. Corasaniti M. T., Bagetta G., Rodino P., Gratteri S. and Nistico G. (1992) Neurotoxic effects induced by intracerebral and systemic injection of paraquat in rats. Hum. Exp. Toxicol. 11, 535-539.
13. Czlonkowska A., Kohutnicka M., Kurkowska-Jastrzebska I. and Czlonkowski A. (1996) Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) induced Parkinson's disease mice model. Neurodegeneration 5, 137-143.
14. Dervan A. G., Meshul C. K., Beales M., McBean G. J., Moore C., Totterdell S., Snyder A. K. and Meredith G. E. (2004) Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease. Exp. Neurol. 190, 145-156.
15. Di Monte D. A., Lavasani M. and Manning-Bog A. B. (2002) Environmental factors in Parkinson's disease. Neurotoxicology 23, 487-502.
16. Fleming S. M., Zhu C., Fernagut P. O., Mehta A., DiCarlo C. D., Seaman R. L. and Chesselet M. F. (2004) Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Exp. Neurol. 187, 418-429.
17. Francis J. W., Von Visger J., Markelonis G. J. and Oh T. H. (1995) Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine in mouse striatum. Neurotoxicol. Teratol. 17, 7-12.
18. Gao H. M., Hong J. S., Zhang W. and Liu B. (2002) Distinct role of microglia in rotenone-induced degeneration of dopaminergic neurons. J. Neurosci. 22, 782-790.
19. Gao H. M., Hong J. S., Zhang W. and Liu B. (2003a) Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. J. Neurosci. 23, 1228-1236.
20. Gao H. M., Liu B., Zhang W. et al. (2003b) Novel anti-inflammatory therapy for Parkinson's disease. Trends Pharmacol. Sci. 24, 395-401.
21. Glaser J. R. and Glaser E. M. (2000) Stereology, morphometry, and mapping: the whole is greater than the sum of its parts. J. Chem. Neuroanat. 20, 115-126.
22. Graeber M. B., Streit W. J. and Kreutzberg G. W. (1988) Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J. Neurosci. Res. 21, 18-24.
23. Graeber M. B., Lopez-Redondo F., Ikoma E., Ishikawa M., Imai Y., Nakajima K., Kreutzberg G. W. and Kohsaka S. (1998) The microglia/macrophage response in the neonatal rat facial nucleus following axotomy. Brain Res. 813, 241-253.
24. Grant H., Lantos P. L. and Parkinson C. (1980) Cerebral damage in paraquat poisoning. Histopathology 4, 185-195.
25. Hoglinger G. U., Feger J., Prigent A., Michel P. P., Champy P., Ruberg M., Oertel W. H. and Hirsch E. C. (2003) Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J. Neurochem. 84, 491-502.
26. Hughes J. T. (1988) Brain damage due to paraquat poisoning: a fatal case with neuropathological examination of the brain. Neurotoxicology 9, 243-248.
27. Hunot S. and Hirsch E. C. (2003) Neuroinflammatory processes in Parkinson's disease. Ann. Neurol. 53, S49-S60.
28. Imai Y., Ibata I., Ito D., Ohsawa K. and Kohsaka S. (1996) A novel gene Iba-1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem. Biophys. Res. Commun. 224, 855-862.
29. Jackson-Lewis V., Jakowec M., Burke R. E. and Przedborski S. (1995) Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4, 257-269.
30. Katzenstein A. L. A. and Askin F. B. (1997) Katzenstein and Askin's Surgical Pathology of non-Neoplastic Lung Disease, 3rd edn, Vol. 13, p. 477. W.B. Saunders, Philadelphia.
31. Kim W. G., Mohney R. P., Wilson B., Jeohn G. H., Liu B. and Hong J. S. (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20, 6309-6316.
32. Kohutnicka M., Lewandowska E., Kurkowska-Jastrzebska I., Czlonkowski A. and Czlonkowska A. (1998) Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). Immunopharmacology 39, 167-180.
33. Kreutzberg G. W. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
34. Langston J., Forno L., Tetrud J., Reeves A. G., Kaplan J. A. and Karluk D. (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann. Neurol. 46, 598-605.
35. Lawson L. J., Perry V. H., Dri P. and Gordon S. (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151-170.
36. Liberatore G. T., Jackson-Lewis V., Vukosavic S., Mandir A. S., Vila M., McAuliffe W. G., Dawson V. L., Dawson T. M. and Przedborski S. (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 5, 1403-1409.
37. Lim K. L., Dawson V. L. and Dawson T. M. (2003) The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects. Ann. NY Acad. Sci. 991, 80-92.
38. Ling Z., Chang Q. A., Tong C. W., Leurgans S. E., Lipton J. W. and Carvey P. M. (2004) Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally. Exp. Neurol. 190, 373-383.
39. Ling Z., Gayle D. A., Ma S. Y., Lipton J. W., Tong C. W., Hong J. S. and Carvey P. M. (2002) In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov. Disord. 17, 116-124.
40. Liou H. H., Chen R. C., Tsai Y. F., Chen W. P., Chang Y. C. and Tsai M. C. (1996) Effects of paraquat on the substantia nigra of the Wistar rats: neurochemical, histological, and behavioral studies. Toxicol. Appl. Pharmacol. 137, 34-41.
41. Liu B. and Hong J. S. (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 304, 1-7.
42. McCormack A. L., Thiruchelvam M., Manning-Bog A. B., Thiffault C., Langston J. W., Cory-Slechta D. A. and Di Monte D. A. (2002) Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol. Dis. 10, 119-127.
43. McCormack A. L. and Di Monte D. A. (2003) Effects of 1-dopa and other amino acids against paraquat-induced nigrostriatal degeneration. J. Neurochem. 85, 82-86.
44. McGeer P. L., Itagaki S., Boyes B. E. and McGeer E. G. (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1291.
45. Miller G. W., Gainetdinov R. R., Levey A. I. and Caron M. G. (1999) Dopamine transporters and neuronal injury. Trends Pharmacol. Sci. 20, 424-429.
46. Ohsawa K., Imai Y., Nakajima K. and Kohsaka S. (1997) Generation and characterization of a microglial cell line, MG5, derived from a p53-deficient mouse. Glia 21, 285-298.
47. Orr C. F., Rowe D. B. and Halliday G. M. (2002) An inflammatory review of Parkinson's disease. Prog. Neurobiol. 68, 325-340.
48. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Co-Ordinates. Academic Press, San Diego.
49. Priyadarshi A., Khuder S. A., Schaub E. A. and Priyadarshi S. S. (2001) Environmental risk factors and Parkinson's disease: a metaanalysis. Environ. Res. 86, 122-127.
50. Rajput A. H. and Uitti R. J. (1987) Paraquat and Parkinson's disease. Neurology 37, 1820-1821.
51. Sanchez-Ramos J. R., Hefti F. and Weiner W. J. (1987) Paraquat and Parkinson's disease. Neurology 37, 728.
52. Satomi Y., Tsuchiya W., Mihara K., Ota M., Kasahara Y. and Akahori F. (2004) Gene expression analysis of the lung following paraquat administration in rats using DNA microarray. J. Toxicol. Sci. 29, 91-100.
53. Schmued L., Albertson C. and Slikker J. W. (1997) Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751, 37-46.
54. Sherer T. B., Betarbet R., Kim J. H. and Greenamyre J. T. (2003) Selective microglial activation in the rat rotenone model of Parkinson's disease. Neurosci. Lett. 341, 87-90.
55. Shimizu K., Ohtaki K., Matsubara K. et al. (2001) Carrier-mediated processes in blood-brain barrier penetration and neural uptake of paraquat. Brain Res. 906, 135-142.
56. Shimizu K., Matsubara K., Ohtaki K., Fujimaru S., Saito O. and Shiono H. (2003) Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats. Brain Res. 976, 243-252.
57. Streit W. J., Semple-Rowland S. L., Hurley S. D., Miller R. C., Popovich P. G. and Stokes B. T. (1998) Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp. Neurol. 152, 74-87.
58. Tawara T., Fukushima T., Hojo N., Isobe A., Shiwaku K., Setogawa T. and Yamane Y. (1996) Effects of paraquat on mitochondrial electron transport system and catecholamine contents in rat brain. Arch. Toxicol. 70, 585-589.
59. Thiruchelvam M., Brockel B. J., Richfield E. K., Baggs R. B. and Cory-Slechta D. A. (2000a) Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease? Brain Res. 873, 225-234.
60. Thiruchelvam M., Richfield E. K., Baggs R. B., Tank A. W. and Cory-Slechta D. A. (2000b) The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J. Neurosci. 20, 9207-9214.
61. Thiruchelvam M., Richfield E. K., Goodman B. M., Baggs R. B. and Cory-Slechta D. A. (2002) Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 23, 621-633.
62. Thiruchelvam M., McCormack A. L., Richfield E. K., Baggs R. B., Tank A. W., Di Monte D. A. and Cory-Slechta D. A. (2003) Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of Parkinson's disease phenotype. Eur. J. Neurosci. 18, 589-600.
63. Yune T. Y., Chang M. J., Kim S. J. et al. (2003) Increased production of tumor necrosis factor-alpha induces apoptosis after traumatic spinal cord injury in rats. J. Neurotrauma 20, 207-219.
64. Zhu C., Vourc'h P., Fernagut P. O., Fleming S. M., Lacan S., Dicarlo C. D., Seaman R. L. and Chesselet M. F. (2004) Variable effects of chronic subcutaneous administration of rotenone on striatal histology. J. Comp. Neurol. 478, 418-426.